Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Xiao, Wen ^a   Bao, Zhe Xuan ^a   Zhang, Chen Yang ^a   Zhang, Xiao Yun ^a   Shi, Lin Jun ^a   Zhou, Zeng Tong ^a   Jiang, Wei Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 3; MICRORNA; MICRORNA 1184; MICRORNA 1259; MICRORNA 142 5P; MICRORNA 146B 5P; MICRORNA 301A; MICRORNA 31; MICRORNA 33A; MICRORNA 519D; MICRORNA 572; MICRORNA 585; MICRORNA 611; MICRORNA 623; MICRORNA 637; MICRORNA 675; MICRORNA 886 3P; MICRORNA 886 5P; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE; CELL IMMORTALIZATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPLAKIA; MALE; MALIGNANT TRANSFORMATION; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR GROWTH; TUMOR RECURRENCE; UPREGULATION;

APOPTOSIS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOPLAKIA, ORAL; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECURRENCE; UP-REGULATION;

EID: 84862507068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038648     Document Type: Article

References (50)

1. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, et al. (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer research 56: 2488.
2. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH, (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral surgery, oral medicine, and oral pathology 46: 518.
3. Van der Hem PS, Nauta JM, der Wal JE, Roodenburg JLN, (2005) The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral oncology 41: 31-37.
4. Neville BW, Day TA, (2002) Oral cancer and precancerous lesions. CA: a cancer journal for clinicians 52: 195-215.
5. Chen CZ, (2005) MicroRNAs as oncogenes and tumor suppressors. The New England Journal of Medicine 353.
6. Wang Y, Lee CGL, (2009) MicroRNA and cancer-focus on apoptosis. Journal of cellular and molecular medicine 13: 12-23.
7. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, et al. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. International journal of cancer 123: 2791-2797.
8. Wong QWL, Lung RWM, Law PTY, Lai PBS, Chan KYY, et al. (2008) MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135: 257-269.
9. Liu C, (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Diseases 16: 360-364.
10. Kim VN, (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 6: 376-385.
11. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, et al. (2009) Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proceedings of the National Academy of Sciences 106: 1502.
12. Guo L, Lu Z, (2010) The Fate of miRNA* Strand through Evolutionary Analysis: Implication for Degradation As Merely Carrier Strand or Potential Regulatory Molecule? PLoS One 5: e11387.
13. Okamura K, Phillips MD, Tyler DM, Duan H, Chou Y, et al. (2008) The regulatory activity of microRNA nast; species has substantial influence on microRNA and 3′ UTR evolution. Nature structural & molecular biology 15: 354-363.
14. Zhang L, Deng T, Li X, Liu H, Zhou H, et al. (2010) microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 31: 559.
15. Hu Y, Correa AM, Hoque A, Guan B, Ye F, et al. (2011) Prognostic significance of differentially expressed miRNAs in esophageal cancer. International journal of cancer.
16. Yu J, Wu J, Zheng L, Zhang B, Ni X, et al. (2009) Journal of Experimental & Clinical Cancer Research. Journal of Experimental & Clinical Cancer Research 28: 55.
17. Liu X, Chen Z, Yu J, Xia J, Zhou X, (2009) MicroRNA profiling and head and neck cancer. Comp Funct Genomics 837514.
18. Hui ABY, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clinical Cancer Research 16: 1129.
19. Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, et al. (2010) Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes, Chromosomes and Cancer 49: 549-559.
20. Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, et al. (2008) Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer science 99: 1147-1154.
21. Zhang C, Wang C, Chen X, Yang C, Li K, et al. (2010) Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clinical chemistry 56: 1871.
22. William WN, Lee JJ, Lippman SM, Martin JW, Chakravarti N, et al. (2009) High-dose fenretinide in oral leukoplakia. Cancer Prevention Research 2: 22.
23. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT, et al. (2006) Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. International journal of oral and maxillofacial surgery 35: 653-657.
24. Zhong LP, Pan HY, Zhou XJ, Ye DX, Zhang L, et al. (2008) Characteristics of a cancerous cell line, HIOEC-B [a] P-96, induced by benzo [a] pyrene from human immortalized oral epithelial cell line. Archives of Oral Biology 53: 443-452.
25. Khvorova A, Reynolds A, Jayasena SD, (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115: 209-216.
26. Fujii T, Masumoto N, Saito M, Hirao N, Niimi S, et al. (2005) Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagnostic Molecular Pathology 14: 103.
27. Axell T, Pindborg JJ, Smith CJ, Waal I, (1996) Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. Journal of oral pathology & medicine 25: 49-54.
28. Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, et al. (2010) miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer research 70: 1635.
29. Shackleford GM, MacArthur CA, Kwan HC, Varmus HE, (1993) Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proceedings of the National Academy of Sciences 90: 740.
30. Benharroch D, Birnbaum D, (1990) Biology of the fibroblast growth factor gene family. Israel journal of medical sciences 26: 212.
31. Dickson C, Acland P, Smith R, Dixon M, Deed R, et al. (1990) Characterization of int-2: a member of the fibroblast growth factor family. Journal of cell science.
32. Chua SS, Ma ZQ, (2002) Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene 21: 1899-1908.
33. Hollmann CA, Kittrell FS, Medina D, Butel JS, (2001) Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Oncogene 20: 7645.
34. Hajitou A, Baramova EN, Bajou K, No V, Bruyneel E, et al. (1998) FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells. Oncogene 17: 2059.
35. Hu L, Sham JST, Xie D, Wen JM, Wang WS, et al. (2007) Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma. Cancer letters 252: 36-42.
36. Fan CS, Wong N, Leung SF, To KF, Lo KW, et al. (2000) Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Human pathology 31: 169-178.
37. Seki A, Yoshinouchi M, Seki N, Kodama J, Miyagi Y, et al. (2000) Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer. International journal of oncology 17: 103.
38. Esteller M, Garcia A, Palones JMM, Cabero A, Reventos J, (1995) Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction. Cancer 75: 2139-2146.
39. Xu J, Tyan T, Cedrone E, Savaraj N, Wang N, (1996) Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection. Genes, Chromosomes and Cancer 17: 172-178.
40. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, et al. (2004) Genome-wide profiling of oral squamous cell carcinoma. The Journal of pathology 204: 326-332.
41. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson JT, et al. (1995) Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes, Chromosomes and Cancer 12: 288-295.
42. Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, et al. (2000) A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes, Chromosomes and Cancer 28: 153-163.
43. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, et al. (2006) Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes, Chromosomes and Cancer 45: 118-125.
44. Sobin LH, Wittekind CH, (2002) UICC (2002) TNM classification of malignant tumors. New York: Wiley&Sons.
45. Xu C, Yu C, Li Y, (2009) Regulation of hepatic microRNA expression in response to ischemic preconditioning following ischemia/reperfusion injury in mice. OMICS A Journal of Integrative Biology 13: 513-520.
46. Silahtaroglu AN, Nolting D, Dyrskj L, Berezikov E, M ller M, et al. (2007) Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nature Protocols 2: 2520-2528.
47. Habbe N, Koorstra JBM, Mendell JT, Feldmann G, Mullendore ME, et al. (2009) MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Springer. pp 1-2.
48. Vindel LL, Christensen IJ, Nissen NI, (1983) Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 3: 328-331.
49. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, et al. (2009) GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic acids research 37: W317.
50. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A, (2007) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome biology 8: R3.